EirGenix Statistics

Total Valuation

EirGenix has a market cap or net worth of TWD 18.78 billion. The enterprise value is 15.09 billion.

Market Cap	18.78B
Enterprise Value	15.09B

Important Dates

The next estimated earnings date is Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

EirGenix has 305.41 million shares outstanding. The number of shares has increased by 0.41% in one year.

Current Share Class	n/a
Shares Outstanding	305.41M
Shares Change (YoY)	+0.41%
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	1.41%
Owned by Institutions (%)	7.52%
Float	195.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	18.62
PB Ratio	2.03
P/TBV Ratio	2.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-21.60
EV / Sales	14.95
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-12.23

Financial Position

The company has a current ratio of 6.28, with a Debt / Equity ratio of 0.10.

Current Ratio	6.28
Quick Ratio	5.46
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	-0.73
Interest Coverage	-148.34

Financial Efficiency

Return on equity (ROE) is -7.25% and return on invested capital (ROIC) is -5.78%.

Return on Equity (ROE)	-7.25%
Return on Assets (ROA)	-5.41%
Return on Invested Capital (ROIC)	-5.78%
Return on Capital Employed (ROCE)	-9.61%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.09
Inventory Turnover	1.24

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.36% in the last 52 weeks. The beta is 0.75, so EirGenix's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	-21.36%
50-Day Moving Average	73.20
200-Day Moving Average	82.14
Relative Strength Index (RSI)	39.10
Average Volume (20 Days)	417,035

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EirGenix had revenue of TWD 1.01 billion and -698.34 million in losses. Loss per share was -2.28.

Revenue	1.01B
Gross Profit	218.99M
Operating Income	-953.80M
Pretax Income	-696.51M
Net Income	-698.34M
EBITDA	-689.66M
EBIT	-953.80M
Loss Per Share	-2.28

Full Income Statement

Balance Sheet

The company has 4.60 billion in cash and 901.30 million in debt, giving a net cash position of 3.70 billion or 12.10 per share.

Cash & Cash Equivalents	4.60B
Total Debt	901.30M
Net Cash	3.70B
Net Cash Per Share	12.10
Equity (Book Value)	9.26B
Book Value Per Share	30.31
Working Capital	5.00B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -311.44 million and capital expenditures -921.67 million, giving a free cash flow of -1.23 billion.

Operating Cash Flow	-311.44M
Capital Expenditures	-921.67M
Free Cash Flow	-1.23B
FCF Per Share	-4.04

Full Cash Flow Statement

Margins

Gross margin is 21.70%, with operating and profit margins of -94.53% and -69.21%.

Gross Margin	21.70%
Operating Margin	-94.53%
Pretax Margin	-69.03%
Profit Margin	-69.21%
EBITDA Margin	-68.35%
EBIT Margin	-94.53%
FCF Margin	n/a

Dividends & Yields

EirGenix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.41%
Shareholder Yield	-0.41%
Earnings Yield	-3.72%
FCF Yield	-6.57%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

EirGenix has an Altman Z-Score of 10.12.

Altman Z-Score	10.12
Piotroski F-Score	n/a